EN

Astrazeneca Plc Ordinary Shares(AZN)

Description

a pharmaceutical company that develops innovative drugs and pharmaceutical preparations

Key stats

Earnings

  1. IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
  2. US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
  3. DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
  4. ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS